MarginProbe Receives FDA Approval
Dune Medical Devices, Inc., announced today that its breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, the MarginProbe System, has received Premarket Approval (PMA) by the United States Food and Drug Administration. The technology significantly improves surgeons’ ability to intra-operatively identify "cancer on the margin” and significantly reduce pathologically positive margins following a patient’s initial lumpectomy surgery.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58891-dune-medical-devices-fda-approval-marginprobe-system-breast-cancer-surgery
- TAGS:
- margin,
- breast,
- devices,
- dune,
- lumpectomy,
- medical,
- surgery,
- cancer,
- marginprobe
What do you think of this story?
iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.


Comments